Moreover investigation in SNP in IGF-1 and IGFR-1 indicate that IGF1-pathway polymorphisms are potential prognostic molecular markers in colorectal cancer and pancreatic cancer. This evidence concerns the gene IGF1 and familial pancreatic carcinoma.